Evidence map›Paper›PMID 33150273›Full record

ArticleJournal of the Endocrine Society2020

Analysis of Glucocorticoid-Related Genes Reveal

Laura N Brenner, Josep M Mercader, Catherine C Robertson, Joanne Cole, Ling Chen, Suzanne B R Jacobs, Stephen S Rich, Jose C Florez

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Hub Genes Associated with the Diagnosis of Diabetic Retinopathy.International journal of general medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Laura N BrennerPulmonary and Critical Care Division, Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0001-6752-0471
Josep M MercaderCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0001-8494-3660
Catherine C RobertsonCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
Joanne ColeCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Ling ChenCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Suzanne B R JacobsCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Stephen S RichCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia.ORCID 0000-0003-3872-7793
Jose C FlorezCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Broad Institute · USUniversity of Virginia · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell ApproachesR01DK122586 · NIDDK · UNIVERSITY OF VIRGINIA · PI GRANT, STRUAN F A, RICH, STEPHEN S. · 2019 to 2022
$4.8M
Systematic identification of functional T1D-associated non-coding SNPs using genetic, transcriptomic and epigenetic methodsDP3DK111906 · NIDDK · UNIVERSITY OF VIRGINIA · PI RICH, STEPHEN S. · 2016 to 2016
$4.0M
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 DiabetesK24DK110550 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2016 to 2020
$812k
Genetics of glucocorticoid-induced hyperglycemiaF32DK115086 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BRENNER, LAURA N · 2017 to 2017
$70k
NCATS NIH HHS UL1 TR001102NIDDK NIH HHS DP3 DK111906NIDDK NIH HHS F32 DK115086NIDDK NIH HHS K24 DK110550NIDDK NIH HHS R01 DK122586
6 · The paper itself

Abstract

Glucocorticoids have multiple therapeutic benefits and are used both for immunosuppression and treatment purposes. Notwithstanding their benefits, glucocorticoid use often leads to hyperglycemia. Owing to the pathophysiologic overlap in glucocorticoid-induced hyperglycemia (GIH) and type 2 diabetes (T2D), we hypothesized that genetic variation in glucocorticoid pathways contributes to T2D risk. To determine the genetic contribution of glucocorticoid action on T2D risk, we conducted multiple genetic studies. First, we performed gene-set enrichment analyses on 3 collated glucocorticoid-related gene sets using publicly available genome-wide association and whole-exome data and demonstrated that genetic variants in glucocorticoid-related genes are associated with T2D and related glycemic traits. To identify which genes are driving this association, we performed gene burden tests using whole-exome sequence data. We identified 20 genes within the glucocorticoid-related gene sets that are nominally enriched for T2D-associated protein-coding variants. The most significant association was found in coding variants in coiled-coil α-helical rod protein 1 (

Indexed as

corticosteroiddiabetesgenetics

Identifiers

PMID33150273
PMCPMC7594651
OpenAlexW3080210564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.